Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2026)

Outset Medical (OM) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $249.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 17.18% year-over-year to $249.5 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 8.82% YoY), while the FY2025 annual figure was $264.5 million, down 4.1% from the prior year.
• Liabilities and Shareholders Equity eased to $249.5 million in Q1 2026 per OM's latest filing, from $264.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $431.7 million in Q1 2022 and bottomed at $249.5 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $325.2 million across 5 years, with a median of $313.8 million in 2023.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 13.67% in 2022 and fell as far as 25.18% in 2022.
• Outset Medical's Liabilities and Shareholders Equity stood at $400.1 million in 2022, then slipped by 21.57% to $313.8 million in 2023, then fell by 12.11% to $275.8 million in 2024, then slipped by 4.1% to $264.5 million in 2025, then fell by 5.69% to $249.5 million in 2026.
• Business Quant data shows OM's Liabilities and Shareholders Equity at $249.5 million in Q1 2026, $264.5 million in Q4 2025, and $277.3 million in Q3 2025.